Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIMDW
Ainos
$0.10
-14.0%
$0.12
$0.03
$0.37
N/AN/A18,487 shs566 shs
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
$13.50
$16.00
$3.00
$95.04
N/AN/A2,005 shs19 shs
Conformis, Inc. stock logo
CFMS
Conformis
$2.26
$2.25
$1.05
$7.25
$17.80M1.3999,585 shs7,000 shs
DHAIW
DIH Holding US
$0.01
$0.01
$0.01
$0.13
N/AN/A138,516 shs9,099 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIMDW
Ainos
0.00%-7.11%-2.20%-60.80%+43.91%
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
0.00%0.00%0.00%-33.17%-67.56%
Conformis, Inc. stock logo
CFMS
Conformis
0.00%0.00%0.00%0.00%0.00%
DHAIW
DIH Holding US
0.00%-11.92%+46.15%-5.00%-70.96%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIMDW
Ainos
N/AN/AN/AN/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/AN/AN/AN/AN/AN/AN/A
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/AN/AN/AN/A
DHAIW
DIH Holding US
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIMDW
Ainos
0.00
N/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
0.00
N/AN/AN/A
Conformis, Inc. stock logo
CFMS
Conformis
0.00
N/AN/AN/A
DHAIW
DIH Holding US
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIMDW
Ainos
$106.21KN/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/AN/AN/AN/AN/A
Conformis, Inc. stock logo
CFMS
Conformis
$57.06M0.31N/AN/A$4.07 per share0.56
DHAIW
DIH Holding US
$64.47MN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIMDW
Ainos
N/AN/A0.00N/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/A0.00N/AN/AN/AN/AN/A
Conformis, Inc. stock logo
CFMS
Conformis
-$50.47M-$5.61N/AN/AN/A-72.72%-86.46%-47.65%N/A
DHAIW
DIH Holding US
N/AN/A0.00N/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIMDW
Ainos
N/AN/AN/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/AN/AN/AN/A
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/A
DHAIW
DIH Holding US
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIMDW
Ainos
N/AN/AN/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/AN/AN/A
Conformis, Inc. stock logo
CFMS
Conformis
0.64
5.07
3.30
DHAIW
DIH Holding US
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
AIMDW
Ainos
N/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/A
Conformis, Inc. stock logo
CFMS
Conformis
10.31%
DHAIW
DIH Holding US
N/A

Insider Ownership

CompanyInsider Ownership
AIMDW
Ainos
N/A
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
N/A
Conformis, Inc. stock logo
CFMS
Conformis
3.80%
DHAIW
DIH Holding US
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
AIMDW
Ainos
40N/AN/ANot Optionable
Bone Biologics Co. stock logo
BBLGW
Bone Biologics
2N/AN/ANot Optionable
Conformis, Inc. stock logo
CFMS
Conformis
2957.88 million7.58 millionNot Optionable
DHAIW
DIH Holding US
N/AN/AN/AN/A

Recent News About These Companies

Media Sentiment Over Time

Ainos NASDAQ:AIMDW

$0.10 -0.02 (-14.04%)
As of 06/13/2025 12:22 PM Eastern

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.

Bone Biologics stock logo

Bone Biologics NASDAQ:BBLGW

$13.50 0.00 (0.00%)
As of 06/13/2025

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Conformis stock logo

Conformis NASDAQ:CFMS

Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.

DIH Holding US NASDAQ:DHAIW

$0.01 0.00 (0.00%)
As of 06/13/2025 03:43 PM Eastern

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider in the rehabilitation industry. The company's upper extremity product categories include ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; and Armeo Senso, a sensor-based solution for arm function recovery. It also provides lower extremity product categories comprising Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, an Computer Assisted Rehabilitation Environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, the company offers M-Gait, a modular treadmill system; SafeGait, a balance and mobility trainer; and RYSEN, an 3D bodyweight supporter, as well as software products consist of D-Flow and HocoNet. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.